Poster: Next Generation Risk Assessment (NGRA) for Consumer Products

A key principle of Next Generation Risk Assessment (NGRA) is that modern, non-animal risk assessments should be exposure-led. This means that in vitro methods that are used to make decisions about human safety must be quantitative, so that any predictions relating to dose can be interpretable in the context of actual levels of consumer exposure. Interpreting dose-response data from in vitro toxicity assays requires an understanding of both cellular exposure in the in vitro assays and how these relate to in vivo concentrations (local or systemic). This poster, presented at the 24th World Congress of Dermatology, gives an overview of the NGRA process.

View the poster here.


Comments are closed.